Scott McClellan, MD, on Current Trends and Future Trajectories in Cell Therapy
The chief medical officer of Orca Bio discussed some trends he was excited about at ASH’s 2023 conference.
Scott McClellan, MD, on Overcoming Limitations of AlloHSCT With Novel Cell Therapies
The chief medical officer of Orca Bio discussed data the company presented on its Orca-T and Orca-Q programs at ASH 2023.